| scholarly article | Q13442814 |
| P50 | author | Christopher I Amos | Q90928339 |
| P2093 | author name string | H Robert Frost | |
| Stephanie L Schmit | |||
| Yasmin Kamal | |||
| Hannah J Hoehn | |||
| P2860 | cites work | MYC, Metabolism, and Cancer | Q26783555 |
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content | Q28270471 | ||
| Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
| An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
| Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 | Q29617043 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| Iterative rank-order normalization of gene expression microarray data | Q30621240 | ||
| Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 | ||
| FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines | Q33935206 | ||
| Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology | Q34343405 | ||
| Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. | Q34392567 | ||
| The Molecular Signatures Database (MSigDB) hallmark gene set collection | Q34509167 | ||
| Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q34664272 | ||
| GATA Transcription Factors and Cancer | Q34972814 | ||
| Molecular signatures database (MSigDB) 3.0. | Q35019708 | ||
| A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways | Q35163974 | ||
| Lung resection for colorectal metastases. 10-year results | Q35283181 | ||
| Implementing personalized medicine in a cancer center | Q35619239 | ||
| Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells | Q35783743 | ||
| The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
| Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer | Q36280164 | ||
| Camera: a competitive gene set test accounting for inter-gene correlation | Q36280584 | ||
| Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma | Q36405952 | ||
| Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization | Q36414996 | ||
| Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis | Q36467995 | ||
| Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor | Q37128020 | ||
| Extracellular matrix proteins regulate epithelial-mesenchymal transition in mammary epithelial cells | Q37146767 | ||
| Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 | ||
| Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location | Q37992642 | ||
| Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing. | Q38430666 | ||
| A pathology atlas of the human cancer transcriptome | Q38619228 | ||
| Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. | Q38666172 | ||
| Divergent and convergent evolution in metastases suggest treatment strategies based on specific metastatic sites | Q39836588 | ||
| Neoadjuvant chemotherapy affects molecular classification of colorectal tumors | Q41228722 | ||
| Microsatellite instability and colorectal cancer prognosis. | Q46831092 | ||
| A core program of gene expression characterizes cancer metastases | Q47118938 | ||
| Integrative clinical genomics of metastatic cancer | Q48267403 | ||
| Chromosomal instability drives metastasis through a cytosolic DNA response | Q50001777 | ||
| Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. | Q53534960 | ||
| Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles. | Q53574200 | ||
| A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines | Q57978042 | ||
| A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade | Q58547071 | ||
| Computation and application of tissue-specific gene set weights | Q64125156 | ||
| High expression of DNA repair pathways is associated with metastasis in melanoma patients | Q81343404 | ||
| Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q88932345 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 16 | |
| P921 | main subject | colorectal cancer | Q188874 |
| adenocarcinoma | Q356033 | ||
| colorectal carcinoma | Q25493920 | ||
| metastatic colon cancer | Q108566365 | ||
| P304 | page(s) | 4227-4241 | |
| P577 | publication date | 2019-06-25 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes | |
| P478 | volume | 79 |
| Q90045223 | Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients | cites work | P2860 |
Search more.